Article

In assessing surrogate clinical trial end points: Drug safety is a requisite

Journal of Clinical Oncology
DOI: 10.1200/JCO.2014.59.8169
1Citations
Citations of this article
5Readers
Mendeley users who have this article in their library.
Get full text

Cite

CITATION STYLE

APA

Herzog, T. J., Coleman, R. L., Monk, B. J., Armstrong, D. K., & Alvarez, R. D. (2015, May 1). In assessing surrogate clinical trial end points: Drug safety is a requisite. Journal of Clinical Oncology. American Society of Clinical Oncology. https://doi.org/10.1200/JCO.2014.59.8169

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free